Retaglutide is a novel GLP-1 receptor agonist currently under study for the treatment of metabolic disorders. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://rebeccaqgza930372.blogs100.com/39452705/retaglutide-a-promising-glp-1-receptor-agonist